Strata Critical Medical, Inc.
SRTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $417 | $328 | $218 | $338 |
| - Cash | $23 | $59 | $35 | $18 |
| + Debt | $3 | $9 | $9 | $9 |
| Enterprise Value | $398 | $278 | $192 | $328 |
| Revenue | $49 | $71 | $54 | $54 |
| % Growth | -30.4% | 30.4% | -0.1% | – |
| Gross Profit | $12 | $18 | $12 | $13 |
| % Margin | 23.6% | 25.1% | 22.1% | 23.2% |
| EBITDA | -$9 | -$3 | -$6 | -$7 |
| % Margin | -18.7% | -4.5% | -10.8% | -12.6% |
| Net Income | $57 | -$4 | -$3 | -$10 |
| % Margin | 116.5% | -5.3% | -6.4% | -18% |
| EPS Diluted | 0.7 | -0.046 | -0.04 | -0.12 |
| % Growth | 1,621.7% | -15% | 66.7% | – |
| Operating Cash Flow | -$32 | -$4 | -$5 | $0 |
| Capital Expenditures | -$3 | -$3 | -$3 | -$5 |
| Free Cash Flow | -$35 | -$7 | -$8 | -$5 |